ES2139537A1 - Sistema de presentacion de antigenos basado en el virus de la sharka. - Google Patents

Sistema de presentacion de antigenos basado en el virus de la sharka.

Info

Publication number
ES2139537A1
ES2139537A1 ES009800623A ES9800623A ES2139537A1 ES 2139537 A1 ES2139537 A1 ES 2139537A1 ES 009800623 A ES009800623 A ES 009800623A ES 9800623 A ES9800623 A ES 9800623A ES 2139537 A1 ES2139537 A1 ES 2139537A1
Authority
ES
Spain
Prior art keywords
ppv
system based
antigen
modified
antigen presentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009800623A
Other languages
English (en)
Other versions
ES2139537B1 (es
Inventor
Alvarez Jose Ignacio Casal
Torrecuadrada Jorge L Martinez
Fernadez M Del Rosar Fernandez
Alvarez Juan Antonio Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Inmunologia y Genetica Aplicada SA
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Inmunologia y Genetica Aplicada SA filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES9800623A priority Critical patent/ES2139537B1/es
Publication of ES2139537A1 publication Critical patent/ES2139537A1/es
Application granted granted Critical
Publication of ES2139537B1 publication Critical patent/ES2139537B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

El sistema de presentación de antígenos heterólogos basado en el virus de la sharka (PPV) comprende una partícula de PPV quimérica formada por ensamblaje de la proteína de la cápsida (CP) de PPV modificada que contiene, al menos, un antígeno heterólogo en dicha CP modificada, estando dicho antígeno dispuesto en la superficie exterior de dicha partícula viral de PPV. Preferentemente, dicho antígeno heterólogo se encuentra en el extremo amino terminal de la CP modificada de PPV. En una realización concreta se describe la construcción de un sistema de presentación de un epítopo inmunológicamente activo derivado de la proteína VP2 del parvovirus canino (CPV). Estos sistemas de presentación de antígenos tienen utilidad en diagnóstico vacunas.
ES9800623A 1998-03-24 1998-03-24 Sistema de presentacion de antigenos basado en el virus de la sharka. Expired - Fee Related ES2139537B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9800623A ES2139537B1 (es) 1998-03-24 1998-03-24 Sistema de presentacion de antigenos basado en el virus de la sharka.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9800623A ES2139537B1 (es) 1998-03-24 1998-03-24 Sistema de presentacion de antigenos basado en el virus de la sharka.

Publications (2)

Publication Number Publication Date
ES2139537A1 true ES2139537A1 (es) 2000-02-01
ES2139537B1 ES2139537B1 (es) 2000-10-01

Family

ID=8303209

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9800623A Expired - Fee Related ES2139537B1 (es) 1998-03-24 1998-03-24 Sistema de presentacion de antigenos basado en el virus de la sharka.

Country Status (1)

Country Link
ES (1) ES2139537B1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192433A1 (es) * 2000-09-01 2003-10-01 Consejo Superior Investigacion Produccion del antigeno vp60, o de un fragmento del mismo, del virus de la enfermedad hemorragica de los conejos en plantas y vacuna contra la enfermedad hemorragica virica de los conejos que comprende dicho antigeno.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015587A1 (en) * 1990-04-06 1991-10-17 Commonwealth Scientific And Industrial Research Organisation Self-polymerising expression system based on modified potyvirus coat proteins
WO1992017589A1 (es) * 1991-03-26 1992-10-15 Ercros S.A. Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino
US5569823A (en) * 1993-05-28 1996-10-29 Bayer Aktiengesellschaft DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015587A1 (en) * 1990-04-06 1991-10-17 Commonwealth Scientific And Industrial Research Organisation Self-polymerising expression system based on modified potyvirus coat proteins
WO1992017589A1 (es) * 1991-03-26 1992-10-15 Ercros S.A. Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino
US5569823A (en) * 1993-05-28 1996-10-29 Bayer Aktiengesellschaft DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192433A1 (es) * 2000-09-01 2003-10-01 Consejo Superior Investigacion Produccion del antigeno vp60, o de un fragmento del mismo, del virus de la enfermedad hemorragica de los conejos en plantas y vacuna contra la enfermedad hemorragica virica de los conejos que comprende dicho antigeno.

Also Published As

Publication number Publication date
ES2139537B1 (es) 2000-10-01

Similar Documents

Publication Publication Date Title
ES2664505T3 (es) Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
DE69941843D1 (de) Schweine-circovirus und -parvovirus impfstoff
ATE270342T1 (de) Endosomolytisch wirksame partikel
PT1294893E (pt) Modificacao do antigenio nuclear de hepatite b
DE69229703D1 (de) Wiederhergestellte Influenza-Virosomen mit immunostimulierenden und immunoverstärkenden Eigenschaften und diese enthaltende Impfstoffe
WO2000000616A3 (en) Marburg virus vaccines
FI935459A (fi) Deletionsmutanter av noetkreaturens herpesvirus typ 1, vaccin baserade daerpao; diagnostiska redskap foer upptaeckande av deletionsmutanter av noetkreaturens herpesvirus typ 1
EP1013757A3 (en) Attenuated forms of bovine viral diarrhea virus
CA2196097A1 (en) Secreted viral proteins useful for vaccines and diagnostics
AU3142889A (en) A recombinant marek's disease virus and a vaccine
DK1119630T3 (da) Nukleinsyrekonstruktioner til genetisk immunisering
ATE267256T1 (de) Hepatis e-virus antigene und dessen verwendungen
ES2139537A1 (es) Sistema de presentacion de antigenos basado en el virus de la sharka.
CA2132742A1 (en) Synthetic Peptides and Vaccines Against Parvovirus
MXPA02012593A (es) Particulas de tipo virus del virus de la diarrea viral bovina.
AU3830995A (en) Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
WO1993017110A3 (en) A recombinant hepatitis c virus polypeptide
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
CY2540B1 (en) Vaccine against mumps containing a jeryl-lynn virus strain
AU8405798A (en) A swine hepatitis e virus and uses thereof
CA2363493A1 (en) Attenuated forms of bovine viral diarrhea virus
WO1999024466A3 (en) Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
TH58564B (th) อนุภาคไวรัสที่มีอีพิโทปด้านในจากแหล่งภายนอก
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Parment et al. Hepatitis A after a single dose of an inactivated hepatitis A vaccine

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000201

Kind code of ref document: A1

Effective date: 20000201

FD2A Announcement of lapse in spain

Effective date: 20180629